Inovio Pharmaceuticals Inc (INO)

[KR_redondo]

Dr. Philip D. Greenberg one of Inovio's top scientist ... Published on Jul 26, 2013
Cancer Research Institute's Breakthroughs in Cancer Immunotherapy Webinar Series are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. On June 25, 2013, Dr. Philip D. Greenberg, a professor of Medicine (Oncology) and Immunology, in the Fred Hutchinson Cancer Research Center at the University of Washington, described his groundbreaking research on the immunobiology of host T cell responses to infectious viruses and transformed (cancerous or pre-cancerous) cells. Among his notable contributions to the field is his ongoing work to create effective immunotherapies using the adoptive transfer approach, in which populations of T cells that selectively recognize targets found in cancer cells are expanded and reintroduced to the cancer patient. This approach has seen recent successes and is one of the ways scientists hope to unleash the body's natural immune defenses against cancer.

watch the video
link-